This healthcare juggernaut's recent quarterly results prove just how strong its business is.
Sector ETF report for XHE
Smart Beta ETF report for XHE
Sector ETF report for XHE
Both of these stocks look like bargains right now.
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients...
Even if interest rates go up, you likely won't need to worry about these stocks.
The investments you make now could power your portfolio returns for years to come.
/PRNewswire/ -- S&P MidCap 400 constituent Steel Dynamics Inc. (NASD:STLD) will replace Abiomed Inc. (NASD:ABMD) in the S&P 500 and Super Micro Computer Inc....